A contribution of the immune regulation/checkpoint pathway was surprisingly absent, given our knowledge that immunosuppression increases nevus count quite promptly and the recent success of CTLA4 inhibitors in the treatment of melanoma. This evidence concerns the gene CTLA4 and nevus.